Search our news archive and pharma companies…
|
Today's News | Note: News feeds may no longer be available for the articles on this page.
Roche:
Rheumatoid Arthritis Drug Study Meets Endpoint 5:19 AM 12/11/2009
Wall Street Journal
Roche Holding AG said a phase-III trial related to Genentech
and Biogen Idec Inc's drug ocrelizumab met a primary endpoint.
...
Pfizer
Drug Shows Decrease In Breast-Cancer Relapse 5:12 AM 12/11/2009
Wall Street Journal
Pfizer's cancer drug Aromasin reduced relapse risk by 19% in
breast-cancer patients who switched to tablets of that drug after two and a half years.
...
US
FDA panel says Gilead drug aids cystic fibrosis 4:13 AM 12/11/2009
Reuters
A US FDA advisory panel said it found Gilead Sciences Inc's aztreonam
effective as a new treatment for life-threatening lung infections in cystic fibrosis patients.
...
Lilly
Falls as Analysts Fault Drug Research Schedule 6:34 PM 12/10/2009
Bloomberg
Eli Lilly & Co plans to introduce two medicines a year starting in
2013 to replace revenue lost after its top-seller loses patent protection. Analysts are concerned that the new
drugs won’t generate revenue fast enough.
...
Oncothyreon's
cancer vaccine trial starts in Asia 10:43 AM 12/10/2009
Reuters
Oncothyreon Inc's development partner Merck KGaA started a late-stage trial of its
cancer vaccine Stimuvax in patients in Asia with advanced non-small cell lung cancer (NSCLC).
...
UK
study confirms H1N1 far less lethal than feared 9:49 AM 12/10/2009
Reuters
The study echoes US research published which found the H1N1 pandemic had
a death rate only a bit more serious than an average flu season. The sky may not be falling as postulated by
the Obama administration.
...
Roche:
2 Drugs With Potential To Succeed Herceptin 8:32 AM 12/10/2009
Wall Street Journal
Roche Holding is developing T-DM1 and pertuzumab which have
the potential to eventually succeed blockbuster drug Herceptin as breast cancer treatments.
...
Cytokinetics,
GlaxoSmithKline end cancer drug deal 4:42 PM 12/9/2009
Reuters
Cytokinetics Inc agreed with GlaxoSmithKline to end a collaboration and license
agreement for Cytokinetics' experimental oncology drug GSK-923295 to treat advanced refractory solid tumors.
...
Immunogen
Reports Positive Breast Cancer Drug Data 2:22 PM 12/9/2009
ABC News
Immunogen Inc said its developing cancer treatment T-DM1 showed a good
response rate in a midstage study on breast cancer patients.
...
EU
raids pharma firms over suspected abuse 10:17 AM 12/9/2009
Reuters
Without naming companies, European Union antitrust authorities reported raids on
pharmaceutical companies in a EU member states on suspicion of abusing dominant positions in the market.
...
Glaxo
starts new trial on clogged arteries drug 9:16 AM 12/9/2009
Reuters
GlaxoSmithKline starts a second large-scale clinical trial with
experimental heart drug darapladib.
...
Sangamo
drug helps muscle in 1/3 of ALS patients 6:13 AM 12/9/2009
Reuters
Sangamo BioSciences Inc's drug SB-509 gave improved muscle function after
about four months in nearly a third of amyotrophic lateral sclerosis (ALS) patients.
...
Pfizer
Seeks Boost From Biotech Drugs Within 5 Years 5:15 AM 12/9/2009
Bloomberg
Pfizer Inc hopes to sell copies of medicines like Amgen Inc’s anemia therapy
Epogen or Sanofi-Aventis’ blood thinner Lovenox.
...
US
panel sees higher skin risk with some MRI drugs 4:44 AM 12/9/2009
Reuters
The FDA advisory panel thinks GE's Omniscan and Covidien's Optimark
should carry a warning saying they should not be used in patients with severe kidney disease.
...
US
FDA panel has child weight concerns about drug 2:12 AM 12/9/2009
Reuters
A US FDA advisory panel said current labeling for pediatric uses of
Bristol-Myers Squibb Co's antipsychotic drug Abilify (aripiprazole) does not adequately warn of the risk of
excessive weight gain.
...
<- Day Earlier | Today's News
|
